Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fingolimod with Endovascular Treatment in Acute Ischemic Stroke
NCT04629872Phase 2Unknown
- Start
- Nov 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of fingolimod in ischemic stroke (2 arms). Primary endpoint: Grade of collateral circulation. Status: unknown.
02
Drugs
fingolimod
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04629872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04629872.